The place of myeloid growth factors in the treatment of hairy-cell leukaemia
| Autor: | A. Fortis, D. Nikzas, C. Christopoulos, E. Anevlavis |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Male
Oncology medicine.medical_specialty Neutropenia Myeloid Injections Subcutaneous medicine.medical_treatment Recurrence hemic and lymphatic diseases Internal medicine Granulocyte Colony-Stimulating Factor medicine Humans Hairy cell leukemia Aged Leukemia Hairy Cell Chemotherapy Leukopenia business.industry Growth factor Hematology medicine.disease Granulocyte colony-stimulating factor Lenograstim medicine.anatomical_structure Immunology medicine.symptom business |
| Zdroj: | Clinical & Laboratory Haematology. 19:149-150 |
| ISSN: | 0141-9854 |
| DOI: | 10.1046/j.1365-2257.1997.00053.x |
| Popis: | A patient with hairy-cell leukaemia was treated with granulocyte colony stimulating factor lenograstim (Granocyte) 300 micrograms daily by subcutaneous injections. His pre-existing neutropenia remitted and the therapy was continued for a total of 4 months. When the therapy was discontinued the neutropenia returned. There was no evidence that the growth factor itself had any disease modifying activity. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text